Filtered By:
Therapy: Hormonal Therapy

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 542 results found since Jan 2013.

Many Breast Cancer Patients Can Safely Skip Chemo, Major Study Finds
CHICAGO (CBS News/AP) — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient’s risk. The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the United States and many more elsewhere the ordeal and expense of these drugs. “The impact is tremendous,” said the study leader, Dr. Joseph Sparano of Montefiore Medical Center in New York. Most wo...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 4, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Breast Cancer Chemotherapy Source Type: news

Hormone Replacement: Timing Is Everything Say New GuidelinesHormone Replacement: Timing Is Everything Say New Guidelines
If prescribed before age 60 years and within 10 years after menopause, the benefits of menopausal hormone therapy outweigh the risks, according to a new global consensus statement. Medscape Medical News
Source: Medscape Medical News Headlines - March 15, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Neutral Effect of Hormones on Cognition in Younger Women Neutral Effect of Hormones on Cognition in Younger Women
New data from WHIMSY suggest that there is no sustained benefit or risk to cognitive function of using hormone therapy in women aged 50 to 55 years. Medscape Medical News
Source: Medscape Medical News Headlines - June 26, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Practice-Changing Results for Metastatic Prostate CancerPractice-Changing Results for Metastatic Prostate Cancer
For patients with metastatic hormone-sensitive prostate cancer, upfront chemotherapy with docetaxel, given at the same time as hormone therapy, prolongs survival, new research shows. Medscape Medical News
Source: Medscape Medical News Headlines - June 1, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

NSAID Use May Reduce Breast Cancer Recurrence in ObeseNSAID Use May Reduce Breast Cancer Recurrence in Obese
Postmenopausal women treated with hormone therapy for estrogen-receptor-positive breast cancer who are overweight or obese had a lower recurrence rate if they also took NSAIDs. Medscape Medical News
Source: Medscape Medical News Headlines - August 14, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Federal Subsidy Improves Drug Adherence in Breast CancerFederal Subsidy Improves Drug Adherence in Breast Cancer
A low-income subsidy program improved adherence to hormone therapy in patients with early breast cancer in all race/ethnic groups. Medscape Medical News
Source: Medscape Medical News Headlines - October 15, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Use of Unapproved Menopausal Hormone Therapy SkyrocketsUse of Unapproved Menopausal Hormone Therapy Skyrockets
The use of compounded 'bioidentical' menopausal hormone therapy not approved by the FDA has surged since the 2001 publication of the Women's Health Initiative. Medscape Medical News
Source: Medscape Medical News Headlines - October 16, 2014 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Gene Test Finds Which Breast Cancer Patients Can Skip Chemo
Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease — good news from a major study that shows the value of a gene-activity test to gauge each patient’s risk. The test accurately identified a group of women whose cancers are so likely to respond to hormone-blocking drugs that adding chemo would do little if any good while exposing them to side effects and other health risks. In the study, women who skipped chemo based on the test had less than a 1 percent chance of cancer recurring far away, such as the liver or lungs, within the next five years. “Y...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 28, 2015 Category: Consumer Health News Authors: miketoole Tags: Health Local News Breast Cancer Chemotherapy Source Type: news

Stopping Hormone Therapy Linked to Cardiovascular DeathStopping Hormone Therapy Linked to Cardiovascular Death
A large Finnish registry study suggests that discontinuation does more harm than good. Medscape Medical News
Source: Medscape Medical News Headlines - October 5, 2015 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Halt Hormone Therapy in Postmenopausal Women After MIHalt Hormone Therapy in Postmenopausal Women After MI
Hormone therapy led to fewer deaths related to first myocardial infarction (MI) in a registry of older women, but after an MI, the treatment seems to do more harm than good. Medscape Medical News
Source: Medscape Medical News Headlines - October 7, 2015 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Menopausal Hormone Therapy: Compounded Products Making GainsMenopausal Hormone Therapy: Compounded Products Making Gains
Pharmacy survey findings have raised concerns at the North American Menopause Society. Medscape Medical News
Source: Medscape Medical News Headlines - December 23, 2015 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Hormone Therapy Safe After Ovarian CancerHormone Therapy Safe After Ovarian Cancer
Hormone therapy use after treatment for nonserous epithelial ovarian cancer was not tied to reduced overall survival, and may have extended disease-free survival in women younger than 55 years. Medscape Medical News
Source: Medscape Medical News Headlines - April 20, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

New Approach to Hormone Therapy Hot Topic at NAMS Conference New Approach to Hormone Therapy Hot Topic at NAMS Conference
An updated position statement on hormone therapy and the nonhormonal management of menopausal symptoms are among the highlights of the North American Menopause Society (NAMS) 2016 Annual Meeting.Medscape Medical News
Source: Medscape Medical News Headlines - September 28, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

' Bioidentical ' Oral Alternative to Compound Hormones on Horizon ' Bioidentical ' Oral Alternative to Compound Hormones on Horizon
New oral fixed-dose combinations of 17- β estradiol and natural progesterone are being developed that, if approved, will offer a regulated alternative to compounded hormonal therapy for menopause symptoms.Medscape Medical News
Source: Medscape Medical News Headlines - April 10, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news